JGC
ETRM

J. Goldman & Co’s EnteroMedics Inc. ETRM Stock Holding History

J. Goldman & Co’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-474
Closed -$129K – 346
2015
Q3 		$129K Sell
474
-86
-15% -$27.5K 0.01% 196
2015
Q2 		$365K Sell
560
-226
-29% -$260K 0.02% 213
2015
Q1 		$755K Buy
786
+524
+200% +$632K 0.05% 237
2014
Q4 		$391K Hold
262
– – 0.05% 166
2014
Q3 		$338K Buy
262
+62
+31% +$90.9K 0.02% 259
2014
Q2 		$328K Buy
+200
New +$374K 0.02% 218

Other funds holding ETRM

PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

J. Goldman & Co's ETRM Position: Q4 2015 in Review

J. Goldman & Co sold out of EnteroMedics Inc. (ETRM) in Q4 2015, closing a stake of 474 shares — an estimated $129K sold.

J. Goldman & Co first reported a position in ETRM in Q2 2014 and held it in 6 quarters. The position peaked at $755K in Q1 2015. 33 funds tracked by Wall St. Rank hold ETRM as of Q4 2015.

  • J. Goldman & Co reported no remaining EnteroMedics Inc. position as of Q4 2015 after selling out during the quarter.
  • J. Goldman & Co sold 474 EnteroMedics Inc. shares in Q4 2015, an estimated $129K.
  • J. Goldman & Co first reported a position in EnteroMedics Inc. in Q2 2014 and held it in 6 quarters.
  • J. Goldman & Co's EnteroMedics Inc. position peaked at $755K in Q1 2015.
  • 33 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2015.

Based on J. Goldman & Co's 13F filing for Q4 2015, filed 10 Feb 2016.